Out of puff: Second-quarter revenue at Connecticut-based Marlboro-maker Philip Morris International (PMI) rose 7.1% from a year earlier, to $10.1bn – slightly short of analysts’ expectations of $10.3b

In 2005, BP was No. 2 on the Fortune Global 500 and was carving out a role as an early adapter to the green energy transition. Now there’s speculation about whether the struggling $85 billion supermajor will survive as a freestanding company.

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

CITY

Top companies are increasingly being headed by people of Indian descent. What makes them so successful?

Fundamental problems affecting profitability can’t be fixed until the current models are replaced